CA-15.3
Talk to Health Expert
CA-15.3
₹1500
This assay is useful for predicting early recurrence in women treated for Carcinoma Breast. It is specially useful for serial testing in women with prior Stage II / III breast cancer who are clinically free of disease.
Test information: Fasting not necessary, but preferred
Reporting: Within 48 hours*
- Fasting is not necessary but preferred.
* For details, please see service-related policies
You’ve added CA-15.3 to your cart
Enter your details to confirm booking
Health Articles
ECHO Test Advanced Cardiac Imaging for Heart Func…
📅 18 Feb, 2026 | ✍️ By Molecular Diagnostics and Therapy LLP
DTPA Scan Kidney Function and Renal Drainage Eval…
📅 18 Feb, 2026 | ✍️ By Molecular Diagnostics and Therapy LLP
CEMRI vs MRI Scan Understanding Contrast, Cost, S…
📅 17 Feb, 2026 | ✍️ By Molecular Diagnostics and Therapy LLP
Fibro Scan Test Non-Invasive Assessment of Liver …
📅 17 Feb, 2026 | ✍️ By Molecular Diagnostics and Therapy LLP